Venture Catalysts exits health supplements seller TruNativ with 12.7x return

Venture Catalysts has completed a full exit from the nutrition and wellness firm TruNativ , following two funding rounds. The initial investment made in June 2021 generated a 12.73x return multiple and an approximate 67% internal rate of return (IRR) over a five-year holding period. The follow-on investment executed in September 2024, through the angel fund, yielded a 1.34x multiple and an 18% IRR over a 21-month period. (The company recently attracted funding from OrbiMed, Rainmatter and Emami.)Founded in 2019, TruNativ is a direct-to-consumer brand with a product portfolio which includes a heat-resistant, flavourless whey protein designed for Indian cooking, alongside natural sugar replacers, collagen, and prebiotic fibres, all aimed at addressing macronutrient deficiencies.